LBPH Insider Trading
Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 4.64%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $2,092,097.16
Longboard Pharmaceuticals Insider Trading History Chart
This chart shows the insider buying and selling history at Longboard Pharmaceuticals by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
Longboard Pharmaceuticals Share Price & Price History
Current Price: $59.98
Price Change: ▲ Price Increase of +0.02 (0.03%)
As of 12/2/2024 09:00 PM ET
Longboard Pharmaceuticals Insider Trading History
SEC Filings (Institutional Ownership Changes) for Longboard Pharmaceuticals (NASDAQ:LBPH)
63.28% of Longboard Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.
Institutional Buying and Selling by Quarter
This chart shows the instiutional buying and selling at LBPH by year and by quarter.
Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
Longboard Pharmaceuticals Institutional Trading History
Data available starting January 2016
Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel and transformative medicines for neurological diseases. The company develops bexicaserin (LP352), which has completed Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. It also develops LP659, an S1P receptor modulator for the treatment of neurological diseases. The company was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California.
Read More on Longboard Pharmaceuticals
Today's Range
Now: $59.98
52 Week Range
Now: $59.98
Volume
655,700 shs
Average Volume
924,556 shs
Market Capitalization
$2.34 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1
Who are the company insiders with the largest holdings of Longboard Pharmaceuticals?
Who are the major institutional investors of Longboard Pharmaceuticals?
Which major investors are selling Longboard Pharmaceuticals stock?
Within the previous quarter, LBPH stock was sold by these institutional investors:
- Citadel Advisors LLC